August 20, 2012 — A combination of fluticasone furoate and vilanterol (FF/VI) inhaled once daily improves pulmonary function and has a duration of action of longer than 24 hours, according to the findings of a new study published in the August issue of Clinical Therapeutics . The phase 3 multicenter study, led by Joseph A. Boscia, MD, from CU Pharmaceutical Research, Union, South Carolina, included 54 patients randomly assigned to "1 of 18 three-course sequences of placebo and 2 of 3 dose combinations of FF/VI (50/25 μg, 100/25 μg, and 200/25 μg), dosed once daily in the morning." The researchers found that all 3 strengths of FF/VI showed improvement in forced expiratory volume in 1 second (FEV 1 ) compared with placebo: adjusted mean improvements from baseline for FF/VI were 220 to 236 mL (all, P < .001). Improvements in serial FEV 1 measurements were observed at each time from 0 to 25 hours and with each strength of drug compared with plac...